OraPharma, Inc. is a specialty pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of periodontal disease at various phases of progression. ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg ( www.arestin.com) is indicated as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis.
View Top Employees from OraPharma , Inc.| Website | http://www.orapharma.com |
| Revenue | $29.4 million |
| Employees | 6 (6 on RocketReach) |
| Address | 400 Somerset Corporate Blvd 8-3030, Bridgewater, New Jersey 08807, US |
| Phone | (866) 273-7846 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | AtheroGenics , Inc., Chiesi USA, Inc., Corcept Therapeutics, Enzon Pharmaceuticals, Heron Therapeutics, Inc. |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular OraPharma , Inc. employee's phone or email?
OraPharma , Inc. Questions
The OraPharma , Inc. annual revenue was $29.4 million in 2023.
6 people are employed at OraPharma , Inc..
OraPharma , Inc. is based in Bridgewater, New Jersey.
The NAICS codes for OraPharma , Inc. are [32541, 325, 3254, 32].
The SIC codes for OraPharma , Inc. are [28, 283].
Top OraPharma , Inc. Employees
-
41
-
2
-
3
-
21
Related Companies
